Literature DB >> 2695240

LHRH analogues in the treatment of cancer.

I M Jackson1, M J Matthews, J M Diver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2695240     DOI： 10.1016/0305-7372(89)90008-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters.

Authors:  K H Baumann; L Kiesel; M Kaufmann; G Bastert; B Runnebaum
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.

Authors:  T Reissmann; P Hilgard; J H Harleman; J Engel; A M Comaru-Schally; A V Schally
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.

Authors:  M Dowsett; A Mehta; J Mansi; I E Smith
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.